These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19004556)

  • 1. The impact of selective publication on clinical research in pain.
    Rowbotham MC
    Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
    [No Abstract]   [Full Text] [Related]  

  • 2. Industry-sponsored clinical research: a broken system.
    Angell M
    JAMA; 2008 Sep; 300(9):1069-71. PubMed ID: 18768418
    [No Abstract]   [Full Text] [Related]  

  • 3. Ghostwriters, data manipulation and dollar diplomacy: how drug companies pull the strings in clinical research.
    Berger E
    Ann Emerg Med; 2008 Aug; 52(2):137-9. PubMed ID: 18672488
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflicting interests: the evolution of an issue.
    Healy D
    Monash Bioeth Rev; 2004 Oct; 23(4):8-18. PubMed ID: 15688509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research dishonesty and conflict of interest.
    Frizelle F
    N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical and political problems with a global research tax.
    Resnik DB
    Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971
    [No Abstract]   [Full Text] [Related]  

  • 7. Unravelling industry bias in clinical trials.
    Gluud LL
    Pain; 2006 Apr; 121(3):175-176. PubMed ID: 16513277
    [No Abstract]   [Full Text] [Related]  

  • 8. Independent medical research.
    van der Meer JW; de Gier AM; van Swaaij WP; Katan MB
    Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759
    [No Abstract]   [Full Text] [Related]  

  • 9. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence (letter to the editor): Trend gives cause for concern.
    Maier C; Zenz M
    Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257
    [No Abstract]   [Full Text] [Related]  

  • 11. Research funding, conflicts of interest, and the meta-methodology of public relations.
    Rampton S; Stauber J
    Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
    [No Abstract]   [Full Text] [Related]  

  • 12. The perverse consequences of a proposed global tax on research.
    MacDonald C; Walton N
    Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972
    [No Abstract]   [Full Text] [Related]  

  • 13. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward.
    Samson K
    Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug research: marketing before evidence, sales before safety.
    Klemperer D
    Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conflicts of interest--an evidence-based approach].
    Slørdal L; Eggen AE; Rygnestad T
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864
    [No Abstract]   [Full Text] [Related]  

  • 16. Achieving greater independence from commercial influence in research.
    Lexchin J; Bero LA; Davis C; Gagnon MA
    BMJ; 2021 Mar; 372():n370. PubMed ID: 33687982
    [No Abstract]   [Full Text] [Related]  

  • 17. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 18. Financial disclosure for review authors.
    Nat Neurosci; 2003 Oct; 6(10):997. PubMed ID: 14513027
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of pharmaceutical industry funding on clinical research.
    Lexchin JR
    Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial policies on financial disclosure.
    Carroll BJ; Rubin RT
    Nat Neurosci; 2003 Oct; 6(10):999-1000; author reply 1000-1. PubMed ID: 14513028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.